Tuesday, September 15, 2026

Incheon Airport on Alert as North Korea’s ‘Garbage Balloons’ Float By!

North Korea's balloons enter Yeongjongdo airspace, prompting heightened alert at Incheon Airport after a recent runway incident.

Kim let Citizens Run to Celebrate ’80th Workers’ Party Anniversary’ but Who Needs Exercise Actually?

North Korea's Workers' Party celebrates its 80th anniversary with a wave of loyalty letters and national pride, highlighted by major achievements.

New Breakthrough Could Unlock the Secrets of Supermassive Black Holes

A significant breakthrough today in addressing the final parsec problem, which affects the formation of supermassive black holes.

Health

Celltrion Submits U.S. Phase 4 IND for High-Dose 240 mg Zymfentra

Celltrion has submitted a U.S. Phase 4 trial application to support the use of a higher 240 mg dose of Zymfentra, aiming to expand personalized dosing options and strengthen the drug's position in the U.S. market.

Blood Proteins May Offer Clues to Alzheimer’s Antibody Treatment Benefits and Side-Effect Risks

A South Korean study found that blood levels of complement proteins C1q and C3 may help predict amyloid reduction and ARIA risk in patients receiving lecanemab, though larger studies are needed.

Pentrym Confirms Combination Benefits With Existing Cancer Drugs, Targets “False Resistance”

Pentrym is testing whether targeting the tumor microenvironment alongside existing cancer drugs can overcome “false resistance” and improve treatment effectiveness.

YH42946: The Promising HER2 Targeted Oral Treatment Set to Transform Cancer Care in 2026

Yuhan Corporation will reveal early results of its oral HER2-targeted therapy candidate 'YH42946' in clinical trials by year-end.

SK Biopharm Achieves MSCI ESG AAA Rating for 3rd Consecutive Year: What It Means for the Pharma Industry

SK Biopharm has achieved the highest AAA rating in MSCI's ESG evaluation for three consecutive years.
Latest

Celtrion’s Steqeyma Seizes 16% Market Share in the U.S.: What’s Next for This Autoimmune Treatment?

Celltrion's autoimmune drug Steqeyma surpasses 16% market share in the U.S., accelerating prescription growth and expansion.

Pharos iBio and Kolon Pharmaceutical Expand Joint Development of Lung Cancer Drug

Pharos iBio and Kolon Pharmaceutical are stepping up development of PHI-701, a next-generation EGFR inhibitor targeting patients who have developed resistance to existing targeted lung cancer treatments.

Rokit Healthcare Secures Singapore Patent for Skin Regeneration Patch Technology

Rokit Healthcare has secured a Singapore patent for a personalized skin regeneration patch technology and plans to use the country as a base for expanding into Southeast Asia’s regenerative medicine market.

Samsung Seoul Hospital Performs 1 in 5 Gastric Cancer Surgeries With Robots

Samsung Seoul Hospital has performed 1,500 cumulative robotic gastric cancer surgeries, with robot-assisted procedures accounting for 22% of all gastric cancer surgeries last year.

Alteogen Signs Subcutaneous Injection Development Deal With Novartis Worth Up to $3.22 Billion

Alteogen has signed an option and licensing agreement with Novartis to develop and commercialize subcutaneous formulations based on its ALT-B4 technology, with potential payments of up to $3.22 billion plus royalties.

How Mediwhale’s Dr. Noon CVD Uses AI to Revolutionize Cardiovascular Risk Assessment

Mediwhale presents clinical applications of retinal image analysis for cardiovascular risk assessment at the European Cardiology Congress.

JAYJUN Wins China’s No. 1 Mask Pack Brand of the Year for 10th Consecutive Year

JAYJUN has retained the top spot in China’s mask pack category for 10 consecutive years and received the Masterpiece award recognizing its decade-long winning streak.

SK Biopharmaceuticals Introduces 128 NVIDIA B200 GPUs, Accelerating AI-Driven Drug Discovery

SK Biopharmaceuticals has secured 128 NVIDIA B200 GPUs to build large-scale AI infrastructure, accelerate AI-driven drug discovery, strengthen TR-AX, and explore new AI-based research business models.

Asia MSD Applies for Fast-Track Listing Pilot Program for Pulmonary Arterial Hypertension Drug Winrevair

Asia MSD has applied to a government fast-track listing pilot program aimed at accelerating National Health Insurance coverage for Winrevair, a novel pulmonary arterial hypertension treatment.

“Second-Half Performance to Outpace First Half”… Celltrion Expected to Exceed Full-Year Revenue Target

Celltrion is expected to outperform its first-half results in the second half, driven by new-product growth, European tender wins and stronger demand for high-margin products, potentially allowing it to exceed its full-year targets.

South Korea Begins Its First Advanced Regenerative Medicine Treatment Using ViGenCell Therapy

ViGenCell’s VT-EBV-N has begun South Korea’s first approved advanced regenerative medicine treatment, giving patients with high-risk EBV-positive lymphoma access to a personalized T-cell therapy while generating real-world clinical and manufacturing data.

Revolutionizing Kidney Stone Surgery: How the AI-Powered Zamenix Robot Enhances Patient Safety

ROEN surgical has received regulatory approval for its AI-based kidney stone surgery robot Zamenix and related devices.

Revolutionary Liver Cancer Treatment: How Rivoceranib + Camrelizumab Outperforms Sorafenib in Young Patients

HLB's liver cancer drug combo shows consistent efficacy across all age groups.

Revolutionizing Knee Treatment: How MIUChon iPSC Therapy Could Replace Joint Surgery by 2026

iPSC-based company YiPSCELL accelerates clinical trials for cartilage cell treatment MIUChon, aiming for new options before joint surgery.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.